Amr Salah Abouzied

Dr. Amr Salah Abouzied

University of Ha'il, Ha'il, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2023 in ACS Omega
Verified
Journal Article
Open access
Yasser Hussein Issa MohammedYasser Hussein Issa Mohammed
Yasser Hussein Issa Mohammed
SASaad Alghamdi
Saad Alghamdi
BJBasit Jabbar
Basit Jabbar
DMDina Marghani
Dina Marghani
SBSaba Beigh
Saba Beigh
WHWael N. Hozzein
Wael N. Hozzein
Excessive use of antimicrobial medications including antibiotics has led to the emerging menace of antimicrobial resistance, which, as per the World Health Organization (WHO), is among the top ten public health threats facing humanity, globally. This necessitates that innovative technologies be sought that can aid in the elimination of pathogens and hamper the spread of infections. Zinc oxide (ZnO) has multifunctionality owing to its extraordinary physico-chemical properties and functionality in a range of applications. In this research, ZnO nanoparticles (NPs) were synthesized from zinc nitrate hexahydrate, by a green synthesis approach using Cymbopogon citratus extract followed by characterization of the NPs. The obtained X-ray diffraction peaks of ZnO NPs matched with the standard JCPDS card (no. 89-510). The particles had a size of 20-24 nm, a wurtzite structure with a high crystallinity, and hexagonal rod-like shape. UV-Vis spectroscopy revealed absorption peaks between 369 and 374 nm of ZnO NPs synthesized from C. citratus extract confirming the formation of ZnO. Fourier transform infrared confirmed the ZnO NPs as strong absorption bands were observed in the range of 381-403 cm-1 corresponding to Zn-O bond stretching. Negative values of the highest occupied molecular orbital-lowest unoccupied molecular orbital for ZnO NPs indicated the good potential to form a stable ligand-protein complex. Docking results indicated favorable binding interaction between ZnO and DNA gyrase subunit b with a binding energy of -2.93 kcal/mol. ZnO NPs at various concentrations inhibited the growth of Escherichia coli and Staphylococcus aureus. Minimum inhibitory concentration values of ZnO NPs against E. coli and S. aureus were found to be 92.07 ± 0.13 and 88.13 ± 0.35 μg/mL, respectively, at a concentration of 2 mg/mL. AO/EB staining and fluorescence microscopy revealed the ability of ZnO NPs to kill E. coli and S. aureus cells. Through the findings of this study, it has been shown that C. citratus extract can be used in a green synthesis approach to generate ZnO NPs, which can be employed as alternatives to antibiotics and a tool to eliminate drug-resistant microbes in the future.
1

Verified
Journal Article
Open access
PDF file
AAAdel Alghamdi
Adel Alghamdi
Amr Salah AbouziedAmr Salah Abouzied
Amr Salah Abouzied
AAAbdulwahab Alamri
Abdulwahab Alamri
Sirajudheen AnwarSirajudheen Anwar
Sirajudheen Anwar
Mukhtar AnsariMukhtar Ansari
Mukhtar Ansari
Sobhi M. GomhaSobhi M. Gomha
Sobhi M. Gomha
Many biological activities of pyridine and thiazole derivatives have been reported, including antiviral activity and, more recently, as COVID-19 inhibitors. Thus, in this paper, we designed, synthesized, and characterized a novel series of N-aminothiazole-hydrazineethyl-pyridines, beginning with a N′-(1-(pyridine-3-yl)ethylidene)hydrazinecarbothiohydrazide derivative and various hydrazonoyl chlorides and phenacyl bromides. Their Schiff bases were prepared from the condensation of N-aminothiazole derivatives with 4-methoxybenzaldehyde. FTIR, MS, NMR, and elemental studies were used to identify new products. The binding energy for non-bonding interactions between the ligand (studied compounds) and receptor was determined using molecular docking against the SARS-CoV-2 main protease (PDB code: 6LU7). Finally, the best docked pose with highest binding energy (8a = −8.6 kcal/mol) was selected for further molecular dynamics (MD) simulation studies to verify the outcomes and comprehend the thermodynamic properties of the binding. Through additional in vitro and in vivo research on the newly synthesized chemicals, it is envisaged that the achieved results will represent a significant advancement in the fight against COVID-19.

27 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Amr Salah AbouziedAmr Salah Abouzied
Amr Salah Abouzied
JAJehan y Al-Humaidi
Jehan y Al-Humaidi
Abdulrahman S BazaidAbdulrahman S Bazaid
Abdulrahman S Bazaid
Husam QanashHusam Qanash
Husam Qanash
NBNaif K BinSaleh
Naif K BinSaleh
Sobhi M. GomhaSobhi M. Gomha
Sobhi M. Gomha
Pyridine, 1,3,4-thiadiazole, and 1,3-thiazole derivatives have various biological activities, such as antimicrobial, analgesic, anticonvulsant, and antitubercular, as well as other anticipated biological properties, including anticancer activity. The starting 1-(3-cyano-4,6-dimethyl-2-oxopyridin-1(2H)-yl)-3-phenylthiourea (2) was prepared and reacted with various hydrazonoyl halides 3a–h, α-haloketones 5a–d, 3-chloropentane-2,4-dione 7a and ethyl 2-chloro-3-oxobutanoate 7b, which afforded the 3-aryl-5-substituted 1,3,4-thiadiazoles 4a–h, 3-phenyl-4-arylthiazoles 6a–d and the 4-methyl-3- phenyl-5-substituted thiazoles 8a,b, respectively. The structures of the synthesized products were confirmed by spectral data. All of the compounds also showed remarkable anticancer activity against the cell line of human colon carcinoma (HTC-116) as well as hepatocellular carcinoma (HepG-2) compared with the Harmine as a reference under in vitro condition. 1,3,4-Thiadiazole 4h was found to be most promising and an excellent performer against both cancer cell lines (IC50 = 2.03 ± 0.72 and 2.17 ± 0.83 µM, respectively), better than the reference drug (IC50 = 2.40 ± 0.12 and 2.54 ± 0.82 µM, respectively). In order to check the binding modes of the above thiadiazole derivatives, molecular docking studies were performed that established a binding site with EGFR TK.

22 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ICIbrahim Chikowe
Ibrahim Chikowe
KBKing David Bwaila
King David Bwaila
SUSamuel Chima Ugbaja
Samuel Chima Ugbaja
Amr Salah AbouziedAmr Salah Abouzied
Amr Salah Abouzied
Plant extracts have been useful for oral health or dentistry. However, only a few evidence-based justifications exist. This study evaluated Multidentia crassa (Hiern) Bridson & Verdc, one of the oral health-used plants in Malawi. Gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared (FT-IR) identified the extracts’ compounds. The pharmacokinetics of the identified compounds were studied using pkCSM and SwissADME, and molecular docking studies were used to identify potential drug candidates for oral health by predicting the binding affinity of the compounds to cyclooxygenases, interleukin-1 beta receptors, odontoblast cold sensor proteins, and purinergic receptor P2X3. FT-IR analysis showed characteristic peaks of phenols, carboxylic acids, alkenes, alkyl halides, amines, esters, ethers, aromatics, and lipids. GC–MS results showed the presence of 58 bioactive phytocompounds, some of which have various pharmacological activities relevant to oral health. Molecular docking further validated stigmastan-3,5-diene’s potency for analgesic and anti-inflammatory purposes. Based on a literature review, this is the first report on the bioactive compounds of M. crassa extracts showing analgesic and anti-inflammatory effects. This study's results can lead to new herbal and conventional medicines. Therefore, we recommend in vivo and in vitro studies to elucidate the pharmacological effects of the plant extracts.

22 November 2018 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
IAIsmail I. Althagafi
Ismail I. Althagafi
Amr Salah AbouziedAmr Salah Abouzied
Amr Salah Abouzied
TFThoraya Farghaly
Thoraya Farghaly
NANadia T. Al‐Qurashi
Nadia T. Al‐Qurashi
MAMohammad Y. Alfaifi
Mohammad Y. Alfaifi
MAMohamed R. Abdel Aziz
Mohamed R. Abdel Aziz

1 December 2020 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
AUAziz Unnisa
Aziz Unnisa
Amr Salah AbouziedAmr Salah Abouzied
Amr Salah Abouzied
ABAnupama Baratam
Anupama Baratam
KLKNV CHENCHU LAKSHMI
KNV CHENCHU LAKSHMI
THTalib Hussain
Talib Hussain
KSKesavanarayanan Krishnan Selvarajan
Kesavanarayanan Krishnan Selvarajan